Inclusion Criteria : 
  -  Diagnosis of GCA as classified according to protocol - specified criteria;
  -  Participants entering Period 1 must be receiving treatment with TCZ 8 mg / kg IV Q4W . 
Exclusion Criteria : 
  -  Treatment with any other investigational agent besides TCZ within 12 weeks ( or 5 half - lives of the investigational drug , whichever is longer ) prior to screening;
  -  Evidence of serious uncontrolled disease;
  -  Known active current or history of recurrent bacterial , viral , fungal , mycobacterial , or other infections;
  -  Active TB requiring treatment within the previous 3 years.